Drugs Information:
Leflunomide
Basic Information
|
||
ID | DDInter1033 | |
Drug Type | small molecule | |
Molecular Formula | C12H9F3N2O2 | |
Molecular Weight | 270.207 | |
CAS Number | 75706-12-6 | |
Description | Leflunomide is a pyrimidine synthesis inhibitor belonging to the DMARD (disease-modifying antirheumatic drug) class of drugs, which are chemically and pharmacologically very heterogeneous. Leflunomide was approved by FDA and in many other countries (e.g., Canada, Europe) in 1999. | |
ATC Classification | L04AA13 | |
IUPAC Name | 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide | |
InChI | VHOGYURTWQBHIL-UHFFFAOYSA-N | |
Canonical SMILES | CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Compound KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Wikipedia ChEMBL ZINC |
Interactions with
Leflunomide
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|